Company · CIK 0000078003 · SIC 2834 — Pharmaceutical Preparations · NYSE
PFIZER INC · PFE
Insider activity reported against this company. All insider holders · Files at: ICUI, ALLO, RYTM, SYBX, NGNE. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 PForm 4 → | Aug 12, 4:04 pm EDT | Albert BourlaChairman & CEO, Director | 38,000 | $26.34 | $1,000,920 | 429,173 | +9.71% | |
| Aug 5, 2026 SForm 4 → | Aug 6, 11:26 am EDT | Jennifer B. DamicoSVP & Controller | 3,278 | $25.40 | $83,261 | 28,611 | −10.3% | |
| Aug 5, 2026 PForm 4 → | Aug 5, 4:03 pm EDT | Ronald E BlaylockDirector | 39,231 | $25.46 | $998,821 | 66,938 | +142% | |
| Aug 5, 2026 PForm 4 → | Aug 5, 4:02 pm EDT | Mortimer J BuckleyDirector | 37,632 | $25.52 | $960,369 | 37,632 | — | |
| Jun 9, 2026 SForm 4 → | Jun 10, 7:58 pm EDT | Jennifer B. DamicoSVP & Controller | 2,000 | $25.70 | $51,400 | 31,397 | −5.99% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 16, 3:17 pm EDT | Albert BourlaChairman & CEO, Director | 22 | $27.55 | $606 | 783,985 | — | |
| Aug 31, 2026 AForm 4 → | Sep 1, 5:54 pm EDT | Albert BourlaChairman & CEO, Director | 21 | $28.46 | $598 | 784,012 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 6:15 pm EDT | Albert BourlaChairman & CEO, Director | 22 | $26.79 | $589 | 785,060 | — | |
| Jul 31, 2026 AForm 4 → | Aug 3, 7:50 pm EDT | Albert BourlaChairman & CEO, Director | 24 | $25.01 | $600 | 786,154 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 6:17 pm EDT | Albert BourlaChairman & CEO, Director | 24 | $24.82 | $596 | 772,901 | — | |
| Jul 9, 2026 AForm 4 → | Jul 13, 3:43 pm EDT | Albert BourlaChairman & CEO, Director | 84 | $24.25 | $2,037 | 772,938 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 3:50 pm EDT | Albert BourlaChairman & CEO, Director | 25 | $24.08 | $602 | 772,979 | — | |
| Jun 26, 2026 AForm 4 → | Jun 30, 3:18 pm EDT | Mortimer J BuckleyDirector | 1,544 | $24.29 | $37,500 | 26,335 | — | |
| Jun 26, 2026 AForm 4 → | Jun 30, 3:18 pm EDT | Joseph EchevarriaDirector | 1,904 | $24.29 | $46,250 | 165,632 | — | |
| Jun 26, 2026 AForm 4 → | Jun 30, 3:16 pm EDT | Shantanu NarayenDirector | 2,058 | $24.29 | $50,000 | 200,879 | — | |
| Jun 26, 2026 AForm 4 → | Jun 30, 3:11 pm EDT | James C SmithDirector | 1,853 | $24.29 | $45,000 | 182,886 | — | |
| Jun 26, 2026 AForm 4 → | Jun 30, 3:10 pm EDT | James QuinceyDirector | 1,595 | $24.29 | $38,750 | 87,994 | — | |
| Jun 26, 2026 AForm 4 → | Jun 30, 3:09 pm EDT | Cyrus TaraporevalaDirector | 1,544 | $24.29 | $37,500 | 36,941 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:21 pm EDT | Albert BourlaChairman & CEO, Director | 23 | $26.00 | $598 | 772,772 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.